Matt Gaetz discusses US-Russia relations and congressional funding challenges

Matt Gaetz discusses US-Russia relations and congressional funding challenges
Congressman Matt Gaetz — Matt Gaetz Official Website
0Comments

Rep. Matt Gaetz, a U.S. Congressman representing Florida’s 1st district since 2017, recently shared his views on various topics through social media posts. Gaetz, who has served in Congress following a tenure in the Florida House of Representatives, continues to engage with his audience on current political matters.

On March 19, 2025, Rep. Gaetz posted about potential cooperation between the United States and Russia. He directed his followers to further details by sharing a link, stating: “How the U.S. & Russia can cooperate https://t.co/02r0dtd9dv”.

Later that day, at 14:33 UTC, he questioned the ability of Congress to defund initiatives with a challenging statement: “Congress can’t defund anything. Prove me wrong.”.

At 15:13 UTC on the same day, Gaetz made another post referencing Laken Riley, implying a disparity in public reactions: “They didn’t cry like this for Laken Riley.”.



Related

Benjamin D. Moncarz Chief Financial Officer - FDA - Official Website

How many companies in cities across Santa Rosa County received FDA citations in 2024?

There was one company in a city associated with Santa Rosa County that received an FDA citation as a result of one inspection conducted in the county in 2024, according to reports from the U.S. Food and Drug Administration (FDA).

Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA - Official Website

Cities located in Santa Rosa County saw an FDA inspection of 1 company in 2024

There was one company in a city associated with Santa Rosa County that received an FDA inspection in 2024, according to the U.S. Food and Drug Administration.

Vid Desai FDA’s Chief Information Officer - Official Website

Cities located in Okaloosa County saw FDA inspections of 2 companies in Q3

There were two companies in cities associated with Okaloosa County that received two FDA inspections in the third quarter of 2025, according to the U.S. Food and Drug Administration.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Emerald Coast Times.